Skip to main content
Top
Published in: Gastric Cancer 2/2017

01-03-2017 | Original Article

A rising trend in the incidence of advanced gastric cancer in young Hispanic men

Authors: Shaila J. Merchant, Joseph Kim, Audrey H. Choi, Virginia Sun, Joseph Chao, Rebecca Nelson

Published in: Gastric Cancer | Issue 2/2017

Login to get access

Abstract

Background

Although the incidence of gastric cancer has been decreasing, recent reports suggest an increased rate in select populations. We sought to evaluate trends in gastric cancer incidence to identify high-risk populations.

Methods

Gastric cancer incidence rates from 1992 to 2011 were computed with use of the Surveillance, Epidemiology, and End Results (SEER) registry. We evaluated trends in incidence rates by calculating the annual percent change (APC) across three age groups (20–49 years, 50–64 years, and 65 years or older) and four racial/ethnic groups (Hispanics, non-Hispanic whites, blacks, and Asian/Pacific Islanders).

Results

We identified 41,428 patients with gastric cancer. For the entire cohort during the study period, the APC was decreased. When patients were grouped according to sex, the APC was flat or decreased in women regardless of age or race/ethnicity. The APC was also flat or decreased for all men except young Hispanic men (20–49 years), who had an increased APC of nearly 1.6 % (1.55 %, 95 % confidence interval 0.26–2.86 %). Furthermore, young Hispanic men were the only group to have increased incidence of stage IV disease (APC 4.34 %, 95 % confidence interval 2.76–5.94 %) and poorly differentiated tumors (APC 2.08 %, 95 % confidence interval 0.48–3.70 %).

Conclusions

The APC of the incidence of gastric cancer in young Hispanic men places it among the top cancers with rising incidence in the USA. This is concomitant with increased incidence of advanced disease at presentation. This major public health concern warrants additional research to determine the cause of the increasing incidence in this group.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Lui FH, Tuan B, Swenson SL, Wong RJ. Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992–2009 SEER data. Dig Dis Sci. 2014;59:3027–34.CrossRefPubMed Lui FH, Tuan B, Swenson SL, Wong RJ. Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992–2009 SEER data. Dig Dis Sci. 2014;59:3027–34.CrossRefPubMed
3.
go back to reference Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80.CrossRefPubMed Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80.CrossRefPubMed
4.
go back to reference Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. J Am Med Assoc. 2010;303(17):1723–8.CrossRef Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. J Am Med Assoc. 2010;303(17):1723–8.CrossRef
5.
go back to reference Al-Refaie WB, Hu CY, Pisters PW, Chang GJ. Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol. 2011;18(10):2800–7.CrossRefPubMedPubMedCentral Al-Refaie WB, Hu CY, Pisters PW, Chang GJ. Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol. 2011;18(10):2800–7.CrossRefPubMedPubMedCentral
6.
go back to reference Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg. 1996;172(5):473–6; discussion 476–7.CrossRefPubMed Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg. 1996;172(5):473–6; discussion 476–7.CrossRefPubMed
7.
go back to reference Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer. 1998;83(1):25–33.CrossRefPubMed Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer. 1998;83(1):25–33.CrossRefPubMed
8.
go back to reference Kim DY, Ryu SY, Kim YJ, Kim SK. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg. 2003;388(4):245–9.CrossRefPubMed Kim DY, Ryu SY, Kim YJ, Kim SK. Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg. 2003;388(4):245–9.CrossRefPubMed
9.
go back to reference Doukkali EB, Winterling J, Eriksson LE, Lampic C, Hagstrom AS, Wettergren L. Adolescents’ and young adults’ experiences of childhood cancer: descriptions of daily life 5 years after diagnosis. Cancer Nurs. 2013;36(5):400–7.CrossRefPubMed Doukkali EB, Winterling J, Eriksson LE, Lampic C, Hagstrom AS, Wettergren L. Adolescents’ and young adults’ experiences of childhood cancer: descriptions of daily life 5 years after diagnosis. Cancer Nurs. 2013;36(5):400–7.CrossRefPubMed
10.
go back to reference Hauken MA, Larsen TM, Holsen I. Meeting reality: young adult cancer survivors’ experiences of reentering everyday life after cancer treatment. Cancer Nurs. 2013;36(5):E17–26.CrossRefPubMed Hauken MA, Larsen TM, Holsen I. Meeting reality: young adult cancer survivors’ experiences of reentering everyday life after cancer treatment. Cancer Nurs. 2013;36(5):E17–26.CrossRefPubMed
11.
go back to reference Buffart TE, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser TB, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol. 2007;211(1):45–51.CrossRefPubMed Buffart TE, Carvalho B, Hopmans E, Brehm V, Kranenbarg EK, Schaaij-Visser TB, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol. 2007;211(1):45–51.CrossRefPubMed
12.
go back to reference Carvalho R, Milne AN, van Rees BP, Caspers E, Cirnes L, Figueiredo C, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol. 2004;204(1):75–83.CrossRefPubMed Carvalho R, Milne AN, van Rees BP, Caspers E, Cirnes L, Figueiredo C, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol. 2004;204(1):75–83.CrossRefPubMed
13.
go back to reference Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, et al. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Adv Med Sci. 2014;59(1):142–6.CrossRefPubMed Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, et al. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Adv Med Sci. 2014;59(1):142–6.CrossRefPubMed
14.
go back to reference Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842–62.CrossRefPubMedPubMedCentral Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842–62.CrossRefPubMedPubMedCentral
15.
go back to reference Milne AN, Sitarz R, Carvalho R, Carneiro F, Offerhaus GJ. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med. 2007;7(1):15–28.CrossRefPubMed Milne AN, Sitarz R, Carvalho R, Carneiro F, Offerhaus GJ. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med. 2007;7(1):15–28.CrossRefPubMed
16.
go back to reference Surveillance, Epidemiology, and End Results (SEER) program November 2013:[SEER*Stat Database: Incidence—SEER 13 Regs Research Data, Nov 2013 Sub (1992–2011) <Katrina/rita population adjustment>—linked to county attributes—total US, 1969–2012 counties, National Cancer Institute, DCCPS, Surveillance Research Program, surveillance systems branch, released April 4, based on the November 3 submission]. http://seer.cancer.gov. Accessed 1 Dec 2014. Surveillance, Epidemiology, and End Results (SEER) program November 2013:[SEER*Stat Database: Incidence—SEER 13 Regs Research Data, Nov 2013 Sub (1992–2011) <Katrina/rita population adjustment>—linked to county attributes—total US, 1969–2012 counties, National Cancer Institute, DCCPS, Surveillance Research Program, surveillance systems branch, released April 4, based on the November 3 submission]. http://​seer.​cancer.​gov. Accessed 1 Dec 2014.
18.
go back to reference Kleinbaum DG, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS-Kent; 1988. Kleinbaum DG, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS-Kent; 1988.
19.
go back to reference Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–69.CrossRefPubMed Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–69.CrossRefPubMed
20.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed
21.
go back to reference Surveillance, Epidemiology, and End Results (SEER) program October 2012: [SEER*Stat Database: Populations—total US (1950–2011) <Katrina/Rita Adjustment>, National Cancer Institute, DCCPS, surveillance research program, surveillance systems branch, released October 2.]. http://seer.cancer.gov. Accessed 1 Dec 2014. Surveillance, Epidemiology, and End Results (SEER) program October 2012: [SEER*Stat Database: Populations—total US (1950–2011) <Katrina/Rita Adjustment>, National Cancer Institute, DCCPS, surveillance research program, surveillance systems branch, released October 2.]. http://​seer.​cancer.​gov. Accessed 1 Dec 2014.
22.
go back to reference Chatenoud L, Bertuccio P, Bosetti C, Malvezzi M, Levi F, Negri E, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25(9):1843–53.CrossRefPubMed Chatenoud L, Bertuccio P, Bosetti C, Malvezzi M, Levi F, Negri E, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25(9):1843–53.CrossRefPubMed
23.
go back to reference Loffeld RJ, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology. 1990;17(6):537–41.CrossRefPubMed Loffeld RJ, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology. 1990;17(6):537–41.CrossRefPubMed
24.
go back to reference Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012;175(1):54–9.CrossRefPubMed Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012;175(1):54–9.CrossRefPubMed
25.
go back to reference Tsai CJ, Perry S, Sanchez L, Parsonnet J. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol. 2005;162(4):351–7.CrossRefPubMed Tsai CJ, Perry S, Sanchez L, Parsonnet J. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol. 2005;162(4):351–7.CrossRefPubMed
26.
go back to reference Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr. 2004;24:401–31.CrossRefPubMed Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr. 2004;24:401–31.CrossRefPubMed
27.
go back to reference Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146(2):357–73.CrossRefPubMed Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014;146(2):357–73.CrossRefPubMed
28.
go back to reference Lifshitz F, Lifshitz JZ. Globesity: the root causes of the obesity epidemic in the USA and now worldwide. Pediatr Endocrinol Rev. 2014;12(1):17–34.PubMed Lifshitz F, Lifshitz JZ. Globesity: the root causes of the obesity epidemic in the USA and now worldwide. Pediatr Endocrinol Rev. 2014;12(1):17–34.PubMed
29.
go back to reference Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014;120(19):3040–8.CrossRefPubMed Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014;120(19):3040–8.CrossRefPubMed
30.
go back to reference Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, et al. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution’s experience over 15 years. J Clin Oncol. 2005;23(13):3094–103.CrossRefPubMed Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, et al. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution’s experience over 15 years. J Clin Oncol. 2005;23(13):3094–103.CrossRefPubMed
31.
go back to reference Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009;144(6):506–10.CrossRefPubMed Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009;144(6):506–10.CrossRefPubMed
32.
go back to reference Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222–31.CrossRefPubMed Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222–31.CrossRefPubMed
34.
go back to reference Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45(1):1–8.CrossRefPubMed Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45(1):1–8.CrossRefPubMed
35.
go back to reference Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12(1):135–8.CrossRefPubMed Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12(1):135–8.CrossRefPubMed
36.
go back to reference Asaka M, Kato M, Sakamoto N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol. 2014;49(1):1–8.CrossRefPubMed Asaka M, Kato M, Sakamoto N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol. 2014;49(1):1–8.CrossRefPubMed
37.
go back to reference Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92.CrossRefPubMedPubMedCentral Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92.CrossRefPubMedPubMedCentral
39.
go back to reference Carozza SE, Howe HL. Patterns of cancer incidence among US Hispanics/Latinos, 1995–2000. Cancer Causes Control. 2006;17(8):1067–75.CrossRefPubMed Carozza SE, Howe HL. Patterns of cancer incidence among US Hispanics/Latinos, 1995–2000. Cancer Causes Control. 2006;17(8):1067–75.CrossRefPubMed
40.
go back to reference Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomark Prev. 2009;18(8):2162–9.CrossRef Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomark Prev. 2009;18(8):2162–9.CrossRef
Metadata
Title
A rising trend in the incidence of advanced gastric cancer in young Hispanic men
Authors
Shaila J. Merchant
Joseph Kim
Audrey H. Choi
Virginia Sun
Joseph Chao
Rebecca Nelson
Publication date
01-03-2017
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2017
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-016-0603-7

Other articles of this Issue 2/2017

Gastric Cancer 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.